Full Breakdown
Antibiotic Resistance Threatens Treatment of Traveler's Diarrhea
12/30/2025, 9:45:12 PM
Rising Antibiotic Resistance in Traveler's Diarrhea
A recent study published in JAMA Network Open highlights a concerning trend regarding the treatment of traveler’s diarrhea, a common ailment affecting international travelers. Researchers, led by Dr. Bhawana Amatya from CIWEC Hospital and Travel Medicine Center in Kathmandu, Nepal, found that the bacteria responsible for this condition are increasingly resistant to two major classes of antibiotics: fluoroquinolones and macrolides. The study analyzed 859 cases of traveler’s diarrhea treated at 58 tropical medicine centers worldwide between April 2015 and December 2022.
The findings indicate significant geographic variations in antibiotic resistance patterns. For instance, approximately 79% of Shigella cases in South Central Asia were resistant to fluoroquinolones, while 78% of cases in South America showed resistance to macrolides. This suggests that the effectiveness of antibiotics can vary greatly depending on the region where the infection is contracted.
Causes of Increasing Resistance
Experts attribute the rise in antibiotic resistance primarily to the overuse of these medications. Dr. David Purow, vice president of medicine and GI endoscopy at Northwell Health, emphasized that bacteria evolve over time, leading to increased resistance. He noted, “Bacteria are smart and they can evolve over time. That’s how resistance develops.” This evolution is exacerbated by the indiscriminate use of antibiotics by travelers who often self-medicate without knowing the specific bacteria causing their illness.
Recommendations for Travelers
Both the researchers and Dr. Purow recommend that travelers experiencing diarrhea consult a healthcare professional for appropriate testing to determine the most effective antibiotic for their specific condition. Many travelers currently carry antibiotics and take them at the first sign of symptoms, which may not be necessary. Dr. Purow suggests that over-the-counter medications can alleviate symptoms without the need for antibiotics, as many gastrointestinal infections resolve on their own.
He cautioned against the premature use of antibiotics, stating, “Just taking antibiotics without knowing specifically what they’re treating can have some ramifications for the global population.” Delaying antibiotic use until symptoms worsen could help mitigate the growing issue of antibiotic resistance.
Conclusion
The study underscores the importance of awareness among travelers regarding the risks of antibiotic resistance in treating traveler’s diarrhea. As resistance patterns vary globally, informed medical guidance is essential for effective treatment and the preservation of antibiotic efficacy.
